[Antiatherogenic effects of endothelium-derived relaxing factor (nitric oxide)].
Iturry-Yamamoto
G
G
Hospital de Clinicas de Porto Alegre-UFRGS.
Alves
A A
AA
Picon
P D
PD
D001161:Arteriosclerosis / Q000517:prevention & control*; D005609:Free Radicals; D006801:Humans; D007962:Leukocytes / Q000502:physiology; D008074:Lipoproteins / Q000097:blood; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors; D017382:Reactive Oxygen Species / Q000502:physiology
D005609:Free Radicals; D008074:Lipoproteins; D010975:Platelet Aggregation Inhibitors; D017382:Reactive Oxygen Species; D009569:Nitric Oxide
Propriedades anti-aterogênicas do fator relaxante derivado do endotélio (óxido nítrico).